文献速递流行病学与生物统计真实世界研究与卫生经济

握力与心血管、呼吸及癌症结局和全因死亡率的关联:基于英国生物银行50万参与者的前瞻性队列研究

Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants.
PubMed 文献 · BMJ · 2018-05-08

OBJECTIVE: To investigate the association of grip strength with disease specific incidence and mortality and whether grip strength enhances the prediction ability of an established office based risk score. DESIGN: Prospective population based study. SETTING: UK Biobank.…

要点

  • 握力每降低5kg,全因死亡率风险比在女性为1.20、男性为1.16(P<0.05)。
  • 肌肉无力(男性握力<26kg、女性<16kg)与多数健康结局风险升高相关。
  • 握力可小幅改善诊室风险评分对全因死亡和心血管结局的预测(C指数变化0.009-0.013)。

核心结论

  • 握力较高与一系列健康结局相关,并能改善基于诊室风险评分的预测能力。
  • 进一步研究需确立握力在风险评分或风险筛查中的潜在临床效用。

研究设计与样本

  • 前瞻性人群为基础的研究,数据来自英国生物银行。

主要发现

  • 女性握力每降低5kg,全因死亡率风险比1.20(95%CI 1.17-1.23),男性为1.16(95%CI 1.15-1.17),均P<0.05。
  • 女性握力每降低5kg,心血管疾病死亡率风险比1.19(95%CI 1.13-1.25),男性为1.22(95%CI 1.18-1.26)。
  • 女性握力每降低5kg,全呼吸系统疾病死亡率风险比1.31(95%CI 1.22-1.40),男性为1.24(95%CI 1.20-1.28);COPD死亡率女性1.24(95%CI 1.05-1.47),男性1.19(95%CI 1.09-1.30)。
  • 女性握力每降低5kg,全癌症死亡率风险比1.17(95%CI 1.13-1.21),男性为1.10(95%CI 1.07-1.13);结直肠癌死亡率女性1.17(95%CI 1.04-1.32)、男性1.18(95%CI 1.09-1.27);肺癌死亡率女性1.17(95%CI 1.07-1.27)、男性1.08(95%CI 1.03-1.13);乳腺癌死亡率1.24(95%CI 1.10-1.39);前列腺癌死亡率1.05(95%CI 0.96-1.15)。
  • 肌肉无力(男性握力<26kg、女性<16kg)与所有健康结局的风险升高相关,但女性结肠癌、男女前列腺癌和肺癌除外。

关键数值与推荐

  • 肌肉无力定义为握力<26kg(男性)或<16kg(女性)。
  • 握力加入基于年龄、性别、确诊糖尿病、体重指数、收缩压和吸烟的诊室风险评分后,C指数变化:全因死亡率0.013,心血管死亡率0.012,心血管疾病发病率0.009。

临床怎么用

  • 握力可作为简便指标用于评估多种疾病和死亡风险,并考虑纳入诊室风险评分或风险筛查。
  • 临床中可关注握力低于26kg(男性)或16kg(女性)的个体,提示肌肉无力相关风险升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association of grip strength with disease specific incidence and mortality and whether grip strength enhances the prediction ability of an established office based risk score. DESIGN: Prospective population based study. SETTING: UK Biobank. PARTICIPANTS: 502 293 participants (54% women) aged 40-69 years. MAIN OUTCOME MEASURES: All cause mortality as well as incidence of and mortality from cardiovascular disease, respiratory disease, chronic obstructive pulmonary disease, and cancer (all cancer, colorectal, lung, breast, and prostate). RESULTS: Of the participants included in analyses, 13 322 (2.7%) died over a mean of 7.1 (range 5.3-9.9) years' follow-up. In women and men, respectively, hazard ratios per 5 kg lower grip strength were higher (all at P<0.05) for all cause mortality (1.20, 95% confidence interval 1.17 to 1.23, and 1.16, 1.15 to 1.17) and cause specific mortality from cardiovascular disease (1.19, 1.13 to 1.25, and 1.22, 1.18 to 1.26), all respiratory disease (1.31, 1.22 to 1.40, and 1.24, 1.20 to 1.28), chronic obstructive pulmonary disease (1.24, 1.05 to 1.47, and 1.19, 1.09 to 1.30), all cancer (1.17, 1.13 to 1.21, 1.10, 1.07 to 1.13), colorectal cancer (1.17, 1.04 to 1.32, and 1.18, 1.09 to 1.27), lung cancer (1.17, 1.07 to 1.27, and 1.08, 1.03 to 1.13), and breast cancer (1.24, 1.10 to 1.39) but not prostate cancer (1.05, 0.96 to 1.15). Several of these relations had higher hazard ratios in the younger age group. Muscle weakness (defined as grip strength <26 kg for men and <16 kg for women) was associated with a higher hazard for all health outcomes, except colon cancer in women and prostate cancer and lung cancer in both men and women. The addition of handgrip strength improved the prediction ability, based on C index change, of an office based risk score (age, sex, diabetes diagnosed, body mass index, systolic blood pressure, and smoking) for all cause (0.013) and cardiovascular mortality (0.012) and incidence of cardiovascular disease (0.009). CONCLUSION: Higher grip strength was associated with a range of health outcomes and improved prediction of an office based risk score. Further work on the use of grip strength in risk scores or risk screening is needed to establish its potential clinical utility.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Celis-Morales CA, Welsh P, Lyall DM, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ. 2018. PMID: 29739772. doi:10.1136/bmj.k1651

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。